PAM activity

There is 1 paper on PAM activity in aging research: 1 observational study in people. The newest story, Oct 4, 2026: “Reduced peptide amidation links to higher Alzheimer's risk”.

Biomarker

1 paper studies it1 finding

See all 1 papers on PAM activity

“Reduced PAM-AMA and lower bio-ADM levels were associated with increased risk of incident AD, but not VD.”
Impaired peptide amidation and risk of incident dementia in the Malmoe preventive project cohortAlzheimer's research & therapy2026doi:10.1186/s13195-026-02173-7
  • Humans1

Effects

1

Vascular dementia

no changein humans1

1 study
  1. PAM activity was not clearly linked with vascular dementia in humans.

    “Reduced PAM-AMA and lower bio-ADM levels were associated with increased risk of incident AD, but not VD.”

    Humansmean follow-up of 4.75 ± 1.3 yearsn = 4,543

    Reduced peptide amidation links to higher Alzheimer's risk

    Alzheimer's research & therapy

More on Vascular dementia

Funding

2 grants since 2018

National Institute on Aging$7.9M

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months
Alzheimer's Research & Therapy

Reduced peptide amidation links to higher Alzheimer's risk

In 4,543 adults, each standard deviation drop in amidation enzyme activity raised incident Alzheimer's risk with an adjusted hazard ratio of 2.30.In 4,543 adults, each standard deviation drop in amidation enzyme activity raised incident Alzheimer's risk with an adjusted hazard ratio of 2.30.

Cohort study of 4,543 peopleAlzheimer's disease